Investigating the utility of the HIV 1 BED capture enzyme immunoassay using cross sectional and longitudinal seroconverter specimens from Africa
The identification of populations at risk of HIV infection is a priority for trials of preventive technologies, including HIV vaccines. To quantify incidence traditionally requires laborious and expensive prospective studies.
- PMID Author:
Karita E, Price M, Hunter E, Chomba E, Allen S, Fei L, Kamali A, Sanders EJ, Anzala O, Katende M, Ketter N